Cell-Easy developed a unique vision of CDMO dedicated to the production of Cell-based Therapy products, this integrated concept is called CDMAO. Beyond conventional CDMO, Cell-Easy is not only focusing on Development & Manufacturing but we are positioning as a real partner for helping Biotech & Pharma to bridge the gap between preclinical and clinical development with in depth expertise on regulatory process scale-up and analytics. Cell-Easy offers customized process development, process scale-up, cGMP manufacturing and unique analytical services for immune cells (engineered CAR-T, NK, …cells, and non-engineered cells) and adult stem cells (MSCs, iPSCs and Exosomes) in both Immuno-Oncology and Regenerative Medicine fields. Cell-Easy is a trusted partner and brings today the infrastructure and know-how while ensuring your projects are delivered on time and budget. Supported by highly motivated and experienced people in the Cell Therapy field, Cell-Easy is committed to driving service excellence and actively contribute to a “Bench to Bedside” culture, putting the health care of patients at the heart of everything.